Source: International Congress 2017 – ILDs: clinical aspects
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Nishikiori (Sapporo, Japan). Adjustment of GAP model for Japanese patients with idiopathic pulmonary fibrosis. 844

Member's Comments

No comment yet.

Related content which might interest you: Validation of GAP score in Danish patients diagnosed with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stage Source: ERJ Open Res, 5 (2) 00127-2018; 10.1183/23120541.00127-2018 Year: 2019 Modified GAP stage as a predictor of acute exacerbation in idiopathic pulmonary fibrosis Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Registry of idiopathic pulmonary fibrosis patients Source: International Congress 2016 – Russia Session Year: 2016 Predictors of physical activity in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – Best abstracts in physical activity and telemedicine Year: 2016 Assessment of nutritional status in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016 Predictor factors of mortality in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 Nutritional assessment in patients with idiopathic pulmonary fibrosis: the NUTRIPF study Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 PP217 – Modeling idiopathic pulmonary fibrosis on a lung-on-chip Source: ERS Lung Science Conference 2021 Year: 2021 Physical activity in idiopathic pulmonary fibrosis Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 Prognostic evaluation in Chinese patients with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF treatment II Year: 2016 Survival predictors in a cohort of patients with idiopathic pulmonary fibrosis biopsy-proven Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012 Approach to diagnosis of idiopathic pulmonary fibrosis Source: International Congress 2016 – Russia Session Year: 2016 Evaluating disease severity in idiopathic pulmonary fibrosis Source: Eur Respir Rev, 26 (145) 170051; 10.1183/16000617.0051-2017 Year: 2017 Onset of symptoms in idiopathic pulmonary fibrosis: A case-control study Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Japanese guideline for the treatment of idiopathic pulmonary fibrosis 2017 Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Never-smoking history as a poor prognostic factor in surgically proven idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Determinants of exercise limitation in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 107s Year: 2005 Analysis of baseline characteristics by emphysema extent in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2017 – ILDs: clinical aspects Year: 2017